Advanced Innovative Partners is a company that aims to tackle the toughest challenges in predictive and personalized healthcare practice. They combine therapeutic and diagnostic practices to elevate early detection and clinical management of diseases. The team includes first-in-class experts in oncology, neurology, clinical development, and regulatory affairs from around the world. They are working to advance new approaches to treat illness with nuclear medicine. They address illnesses for underserved patients, with several of their development initiatives focusing on rare pediatric diseases. They also target hard-to-cure conditions such as Parkinson's Disease and Breast Cancer by leveraging their expertise to advance the clinical management of these diseases.